Literature DB >> 8910911

Altered kinetics and extent of urinary daidzein and genistein excretion in women during chronic soya exposure.

L J Lu1, S N Lin, J J Grady, M Nagamani, K E Anderson.   

Abstract

Soybean consumption may be protective for breast cancer, possibly due in part to the presence of the isoflavones daidzein and genistein, which are weakly estrogenic. The metabolism and disposition of these phytoestrogens during chronic soya exposure were studied on a metabolic unit. Six healthy 22- to 29-year-old women consumed an unrestricted hospital diet for most of the study and ingested 12 oz of soymilk with each meal for one month. At two-week intervals, excretion of isoflavones in urine was studied, during which time the subjects consumed a constant basal diet for three to four days, ingested the full daily 36-oz portion of soymilk within 30 minutes each day for one to two days, and collected urine continuously. Urinary recovery of genistein [initially 23.9 +/- 17.3% (SD) of ingested genistin + genistein], daidzein (initially 66.2 +/- 23.5% of ingested daidzin + daidzein), and equol (initially 28% of the ingested precursors daidzin + daidzein in 1 subject and < 1% in 5 subjects) decreased progressively over four weeks of daily soya ingestion by 42% for genistein (p < 0.05) and 31% for daidzein (p < 0.01) but increased by 3- to 100-fold for equol (4 subjects, p < 0.05). Total amounts excreted and peak levels were similarly affected. The absorption half-lives (t 1/2) for genistein and daidzein were initially 2.7 +/- 0.8 and 1.6 +/- 0.5 hours, respectively, and during four weeks of soymilk ingestion decreased to 2.0 +/- 0.6 (p = 0.04) and 1.4 +/- 0.2 hours (p = 0.06), respectively, suggesting more rapid absorption. The appearance t 1/2 of equol can be estimated for only one subject initially (2.9 hrs), but during four weeks of soya ingestion it could be estimated for three more subjects (4.7 +/- 2.3 hrs). The excretion t 1/2 values for genistein and daidzein were initially 6.7 +/- 0.8 and 4.4 +/- 0.7 hours, respectively, and during four weeks of soymilk ingestion decreased to 4.2 +/- 1.2 (p = 0.005) and 3.2 +/- 1.1 hours (p = 0.005), respectively, suggesting more rapid excretion. For equol, the excretion t 1/2 was initially 9.1 hours (1 subject), and after two and four weeks of soymilk ingestion it was 13.4 +/- 9.7 and 5.5 +/- 1.6 hours (4 subjects, p = 0.046, 2 wks vs. 4 wks), respectively. These results indicate that metabolism and disposition of ingested isoflavones are altered during chronic soya ingestion in women, perhaps from increased metabolic degradation to formation of nonisoflavone metabolites. Increased production of the longer- and stronger-acting estrogenic equol in some women during chronic soymilk ingestion may alter the estrogenic potency of dietary soya isoflavones.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910911     DOI: 10.1080/01635589609514485

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  14 in total

1.  Impact of food matrix on isoflavone metabolism and cardiovascular biomarkers in adults with hypercholesterolemia.

Authors:  Jennifer Ahn-Jarvis; Steven K Clinton; Kenneth M Riedl; Yael Vodovotz; Steven J Schwartz
Journal:  Food Funct       Date:  2012-06-27       Impact factor: 5.396

2.  Daidzein and genistein have differential effects in decreasing whole body bone mineral density but had no effect on hip and spine density in premenopausal women: A 2-year randomized, double-blind, placebo-controlled study.

Authors:  Fatima Nayeem; Nai-Wei Chen; Manubai Nagamani; Karl E Anderson; Lee-Jane W Lu
Journal:  Nutr Res       Date:  2019-07-03       Impact factor: 3.315

3.  Novel effects of phytoestrogenic soy isoflavones on serum calcium and chloride in premenopausal women: A 2-year double-blind, randomized, placebo-controlled study.

Authors:  Lee-Jane W Lu; Nai-Wei Chen; Fatima Nayeem; V-M Sadagopa Ramanujam; Yong-Fang Kuo; Donald G Brunder; Manubai Nagamani; Karl E Anderson
Journal:  Clin Nutr       Date:  2017-11-11       Impact factor: 7.324

4.  Soy isoflavones interact with calcium and contribute to blood pressure homeostasis in women: a randomized, double-blind, placebo controlled trial.

Authors:  Lee-Jane W Lu; Nai-Wei Chen; Fatima Nayeem; Manubai Nagamani; Karl E Anderson
Journal:  Eur J Nutr       Date:  2019-09-18       Impact factor: 5.614

5.  Equol production changes over time in pre-menopausal women.

Authors:  Adrian A Franke; Jennifer F Lai; Ian Pagano; Yukiko Morimoto; Gertraud Maskarinec
Journal:  Br J Nutr       Date:  2011-09-16       Impact factor: 3.718

6.  Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis.

Authors:  Ajita V Singh; Adrian A Franke; George L Blackburn; Jin-Rong Zhou
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

7.  The specific role of isoflavones on estrogen metabolism in premenopausal women.

Authors:  Nagi B Kumar; Alan Cantor; Kathy Allen; Diane Riccardi; Charles E Cox
Journal:  Cancer       Date:  2002-02-15       Impact factor: 6.860

8.  Urinary isoflavone excretion as a compliance measure in a soy intervention among young girls: a pilot study.

Authors:  G Maskarinec; C Oshiro; Y Morimoto; S Hebshi; R Novotny; A A Franke
Journal:  Eur J Clin Nutr       Date:  2005-03       Impact factor: 4.016

9.  Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities.

Authors:  Paola Galluzzo; Maria Marino
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

Review 10.  Absorption, distribution, metabolism, and excretion of isoflavonoids after soy intake.

Authors:  Adrian A Franke; Jennifer F Lai; Brunhild M Halm
Journal:  Arch Biochem Biophys       Date:  2014-06-16       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.